Showing results (31-40 of 420) with videos related to
Sort By:
Pageof 42
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|November 10, 2015
Caffeine intake in pregnancy: Relationship between internal intake and effect on birth weightF Partosch, H Mielke, R Stahlmann, et al.European Journal of Clinical Pharmacology|January 1, 1993
Pharmacokinetics of fenoterol in pregnant and nonpregnant womenR Hildebrandt, H Weitzel, K Warnke, et al.Archives of Toxicology|July 8, 2011
Threshold of toxicological concern values for non-genotoxic effects in industrial chemicals: re-evaluation of the Cramer classificationH Kalkhof, M Herzler, R Stahlmann, et al.European Journal of Clinical Pharmacology|January 1, 1987
Enoxacin--a potent inhibitor of theophylline metabolismJ Beckmann, W Elsässer, U Gundert-Remy, et al.European Journal of Clinical Pharmacology|January 1, 1997
Pharmacokinetics and pharmacodynamics of candesartan after administration of its pro-drug candesartan cilexetil in patients with mild to moderate essential hypertension--a population analysisI Meineke, H Feltkamp, A Högemann, et al.European Journal of Clinical Pharmacology|January 1, 1984
Lack of clinically important interaction between erythromycin and theophyllineR Hildebrandt, U Gundert-Remy, H Möller, et al.European Journal of Clinical Pharmacology|January 1, 1983
Lack of interaction between the tetracyclic antidepressant maprotiline and the centrally acting antihypertensive drug clonidineU Gundert-Remy, E Amann, R Hildebrandt, et al.British Journal of Clinical Pharmacology|December 1, 1982
Differences of sympathomimetic and anticholinergic action of OH-maprotiline and its R (-)-enantiomerO Schmidlin, U Gundert-Remy, W Mäurer, et al.Toxicology Letters|June 13, 2017
Daily uptake of mycotoxins - TDI might not be protective for nursed infantsG H Degen, F Partosch, K Muñoz, et al.Journal of Pharmaceutical Sciences|July 1, 1985
Integrated pharmacokinetics and pharmacodynamics of atropine in healthy humans. II: PharmacodynamicsP H Hinderling, U Gundert-Remy, O Schmidlin, et al.Pageof 42